Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Checkmate Pharmaceuticals Inc (CMPI)

Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Checkmate Pharmaceuticals Inc 245 MAIN STREET 2ND FLOOR CAMBRIDGE MA 02142 USA

www.checkmatepharma.com P: 617-682-3625

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Checkmate Pharmaceuticals Inc. is a clinical stage biotechnology company. It is focused on developing proprietary technology to harness the power of the immune system to combat cancer. The company's product candidate includes CMP-001, which is in clinical stage. Checkmate Pharmaceuticals Inc. is based in Cambridge, United States.

Key Statistics

Overview:

Market Capitalization, $K 231,399
Shares Outstanding, K 22,038
Float, K 8,242
% Float 37.40%
Short Volume Ratio 0.29
% of Insider Shareholders 62.60%
% of Institutional Shareholders 74.56%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -61,410 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -15,870 K

Growth:

1-Year Return 57.19%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.73 on 05/12/22
Next Earnings Date 08/11/22
Earnings Per Share ttm -2.92
EPS Growth vs. Prev Qtr -17.74%
EPS Growth vs. Prev Year -12.31%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CMPI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -83.92%
Return-on-Assets % -74.99%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.20
Book Value/Share 2.50
Interest Coverage 0.00
60-Month Beta -4.84
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar